← OrthoAccel Technologies, Inc.

AcceleDent USA →

Investors

Website
Information for Investors
Contact us
Investor Contact: Michael K. Lowe, CEO

Find out more about the AcceleDent™ System at
AcceleDent™ System

← OrthoAccel Technologies, Inc.

AcceleDent USA →

The AcceleDent™ System is FDA cleared for use within the USA

The AcceleDent™ System is CE Marked for sale for its Intended Purpose as a medical device within the European Union. The AcceleDent™ System has been included in the Australian Register of Therapeutic Goods (ARTG 166667 Class IIa).

2012 OrthoAccel Technologies, Inc